Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2008

01-10-2008 | Research Article

Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed

Authors: Asam Latif, Helen Boardman

Published in: International Journal of Clinical Pharmacy | Issue 5/2008

Login to get access

Abstract

Objective of the study Medicines use review and prescription intervention (‘MUR services’) is the first advanced service within the NHS community pharmacy contract and is a structured review that is undertaken by a pharmacists with patients on multiple medicines. The objective of this study was to investigate factors that influence the number of Medicines use reviews (MURs) performed by community pharmacists and to explore community pharmacists’ attitudes towards the service. Setting This study was conducted with pharmacists who were employed by one UK community pharmacy chain. Method A questionnaire was developed to investigate factors that influence the number of MURs performed and pharmacists’ attitudes towards MURs. It consisted of a series of attitudinal statements together with brief demographic data. Questionnaires were distributed to a sample of 280 pharmacists accredited to provide the service during April and May 2006. Main outcome measure Factors affecting the number of MURs performed and community pharmacists’ attitudes towards MURs. Results Sixty per cent (167/280) of pharmacists returned a completed questionnaire. Twenty-seven per cent of respondents had not performed any MURs, 43% had conducted one to 14 reviews and 31% had conducted 15 or more. Job title affected the number of reviews performed; respondents categorised as ‘Store based’ pharmacists performed significantly more MURs than those working as ‘Locums’ but not significantly more than ‘Managing’ pharmacists. Pharmacists reporting access to an accredited consultation area performed significantly more MURs than those who did not. Those working more than 20 h per week performed significantly more MURs than those working less. Gender, time since qualification, the pharmacy size and those having or currently undertaking a clinical diploma were not found to be associated with the number of MURs performed. Most respondents reported that MURs were an opportunity for pharmacist to use their professional skills in an extended role and patients would benefit from the service. However they reported concerns about GPs opinion of the service, lack of time and support staff to conduct MURs and were unhappy about consultation areas. Conclusion This study demonstrates that pharmacists perceive MURs to be an opportunity for an extended role and of value to patients. However, this study has identified perceived barriers, including the availability of a consultation area suitable for performing MURs, time to perform MURs and support staff. The number of MURs performed by pharmacists appears to be affected by the pharmacists’ job title, their working hours and the presence of a consultation area. Additional support for ‘locum’ pharmacists was also highlighted and may be needed.
Literature
1.
go back to reference Implementing the new community pharmacy contractual framework. Information for primary care trusts. London: Department of Health; 2005. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4109256 (accessed 01/11/2007). Implementing the new community pharmacy contractual framework. Information for primary care trusts. London: Department of Health; 2005. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4109256 (accessed 01/11/2007).
2.
go back to reference From compliance to concordance: achieving shared goals in medicine taking. Royal Pharmaceutical Society of Great Britain and Merck Sharpe & Dohme. London: Royal Pharmaceutical Society of Great Britain; 1997. From compliance to concordance: achieving shared goals in medicine taking. Royal Pharmaceutical Society of Great Britain and Merck Sharpe & Dohme. London: Royal Pharmaceutical Society of Great Britain; 1997.
3.
go back to reference Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992;34:507–13.PubMedCrossRef Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992;34:507–13.PubMedCrossRef
6.
go back to reference National Service Framework for older people. London: Department of Health 2001. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4003066 (accessed 01/11/2007). National Service Framework for older people. London: Department of Health 2001. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4003066 (accessed 01/11/2007).
8.
go back to reference General pharmaceutical services in England and Wales 1996–97 to 2005–06. London: Department of Health; 2006. General pharmaceutical services in England and Wales 1996–97 to 2005–06. London: Department of Health; 2006.
9.
go back to reference Gush A. Is funding for advanced services being misdirected? Pharm J 2006;276:320. Gush A. Is funding for advanced services being misdirected? Pharm J 2006;276:320.
10.
go back to reference Ewen D, Ingram MJ, MacAdam A. The uptake and perceptions of the medicines use review service by community pharmacists in England and Wales. Int J Pharm Pract 2006;14(Suppl 2):B61–2. Ewen D, Ingram MJ, MacAdam A. The uptake and perceptions of the medicines use review service by community pharmacists in England and Wales. Int J Pharm Pract 2006;14(Suppl 2):B61–2.
11.
go back to reference Hall J, Smith I. Barriers to medicines use reviews: comparing the views of pharmacists and PCTs. Int J Pharm Prac 2006;14(Suppl 2):B51–2. Hall J, Smith I. Barriers to medicines use reviews: comparing the views of pharmacists and PCTs. Int J Pharm Prac 2006;14(Suppl 2):B51–2.
12.
go back to reference Blenkinsopp A, Celino G, Bond C, Inch J. Medicines use reviews: the first year of a new community pharmacy service. Pharm J 2007;278:218–23. Blenkinsopp A, Celino G, Bond C, Inch J. Medicines use reviews: the first year of a new community pharmacy service. Pharm J 2007;278:218–23.
13.
go back to reference Domiciliary Medication Management—Home Medicines Review. Helping your patients manage their medicines at home. Commonwealth of Australia: Commonwealth Department of Health and Aged Care; 2001. Domiciliary Medication Management—Home Medicines Review. Helping your patients manage their medicines at home. Commonwealth of Australia: Commonwealth Department of Health and Aged Care; 2001.
14.
go back to reference Rigby D. Medication management reviews gathering momentum. Aust Pharm 2003;22(4):282–8. Rigby D. Medication management reviews gathering momentum. Aust Pharm 2003;22(4):282–8.
15.
go back to reference Hudson K, Frayne N. HMR challenges in a small, rural division of general practice. Aust J Pharm 2003;84:270–3. Hudson K, Frayne N. HMR challenges in a small, rural division of general practice. Aust J Pharm 2003;84:270–3.
16.
go back to reference Bajramovic J, Emmerton L, Tett E. Perceptions around concordance—focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expect 2004;7:221–34.PubMedCrossRef Bajramovic J, Emmerton L, Tett E. Perceptions around concordance—focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expect 2004;7:221–34.PubMedCrossRef
17.
go back to reference Kyle G, Nissen L. A community nurse referral system for HMRs—can it work? Aust Pharm 2006;25(4):326–31. Kyle G, Nissen L. A community nurse referral system for HMRs—can it work? Aust Pharm 2006;25(4):326–31.
18.
go back to reference Emblen G, Miller E. Home medicines review the how and why for GPs. Aust Fam Physician 2004;33:49–51.PubMed Emblen G, Miller E. Home medicines review the how and why for GPs. Aust Fam Physician 2004;33:49–51.PubMed
19.
go back to reference James DH, John DN, Thomas R, Roberts D. General Practitioners’ views about the medicines use review service. Int J Pharm Pract 2007;15(Suppl 2):B57–8. James DH, John DN, Thomas R, Roberts D. General Practitioners’ views about the medicines use review service. Int J Pharm Pract 2007;15(Suppl 2):B57–8.
20.
go back to reference Blenkinsopp A, Celino G, Bond CM, Inch J, Gray N. Community pharmacists’ experience of providing medicines use reviews: findings from the national evaluation of the community pharmacy contractual framework. Int J Pharm Pract 2007;15(Suppl 2):B45–6. Blenkinsopp A, Celino G, Bond CM, Inch J, Gray N. Community pharmacists’ experience of providing medicines use reviews: findings from the national evaluation of the community pharmacy contractual framework. Int J Pharm Pract 2007;15(Suppl 2):B45–6.
21.
go back to reference Connelly D. British pharmaceutical conference. Start enjoying the MUR rollercoaster. Pharm J 2006;277(Suppl):B35. Connelly D. British pharmaceutical conference. Start enjoying the MUR rollercoaster. Pharm J 2006;277(Suppl):B35.
22.
go back to reference Chambers R, Wakley G, Blenkinsopp A. Supporting self care in primary care. Oxon: Radcliffe Publishing; 2006. p. 81–100, ISBN 18-461-9070-3. Chambers R, Wakley G, Blenkinsopp A. Supporting self care in primary care. Oxon: Radcliffe Publishing; 2006. p. 81–100, ISBN 18-461-9070-3.
23.
go back to reference Tann J, Blenkinsopp A. Innovation in community pharmacy: accelerating the speed of change. London: RPSGB 2004. Tann J, Blenkinsopp A. Innovation in community pharmacy: accelerating the speed of change. London: RPSGB 2004.
24.
go back to reference Rogers EM. Diffusion of innovatiosns. 4th ed. New York: The Free Press; 1995. ISBN 00–292–6671-8. Rogers EM. Diffusion of innovatiosns. 4th ed. New York: The Free Press; 1995. ISBN 00–292–6671-8.
Metadata
Title
Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed
Authors
Asam Latif
Helen Boardman
Publication date
01-10-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9203-x

Other articles of this Issue 5/2008

International Journal of Clinical Pharmacy 5/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.